Sun Pharma posts Rs 2,375.5 crore Quarter 2 net profit

Credit: IndiaTimes- Published on November 1, 2023
Sun Pharmaceuticals reported a 5% increase in its consolidated net profit for the second quarter of FY 2024. The company's revenue also rose by 11.3% and its EBITDA came in at Rs 3,179 crore. Sun Pharma's India formulation sales increased by 11.1%, while US formulation sales increased by 4.2%. Sun Pharma also highlighted the...

You are here


Related videos from verified sources

-150 METER UNCUT FOOTAGE OF UNDERWATER ATOMIC BLAST 1958 01:23
Credit: Rumble - Published on November 27, 2023 


Dead Space 2 Game-play | Part 3 | Chapter 3 | I'm Back To Walking Again ✔ 31:48
Credit: Rumble - Published on November 26, 2023 


Vancouver Canucks vs. San Jose Sharks LIVE Play by Play & Reaction
Credit: Rumble - Published on November 26, 2023 


Related news from verified sources

Sun Pharma reported an increase of 11% in gross sales to Rs 12,031 crore with a 5% jump in net profit to Rs 2,375.5 crore for the second quarter ended September....
on November 1, 2023 • IndiaTimes

The country's largest lender SBI on Saturday reported a 9.13 per cent growth in consolidated net profit for the September quarter to Rs 16,099.58 crore. The...
on November 4, 2023 • IndiaTimes

Natco Pharma, a pharmaceutical company based in Hyderabad, has reported a significant increase in its consolidated net profit for the second quarter of the...
on November 14, 2023 • IndiaTimes

You might like